Alkem Laboratories Limited — Updates, 26-12-2025: General Updates
26-12-2025 | 06:59 pm
26-12-2025 | 06:59 pm
Alkem Labs invested ~Rs. 300 Cr in its biosimilars subsidiary, Enzene Biosciences, increasing its stake to 99.61%. The cash injection will support Enzene's capex and working capital needs.
No comments yet. Be the first to comment!
